Zacks Research Forecasts Exelixis’ Q4 Earnings (NASDAQ:EXEL)

Zacks Research Forecasts Exelixis’ Q4 Earnings (NASDAQ:EXEL)

Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Zacks Research increased their Q4 2026 earnings per share estimates for shares of Exelixis in a note issued to investors on Tuesday, July 1st. Zacks Research analyst E. Bagri now anticipates that the biotechnology company will earn $0.76 per share for the quarter, up from their prior estimate of $0.75. The consensus estimate for Exelixis’ current full-year earnings is $2.04 per share. Zacks Research a…